A. Arici et al., REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN-1 GENE-EXPRESSION IN HUMANENDOMETRIAL CELLS IN CULTURES, Molecular and cellular endocrinology, 107(2), 1995, pp. 189-197
Bone marrow-derived leukocytes are present in human endometrium/decidu
a and are believed to serve a variety of functions in this tissue. The
number and type of leukocytes in endometrium/decidua vary with the ho
rmonal milieu of the ovarian cycle, with blastocyst implantation, and
during pregnancy. The factors that regulate the recruitment of specifi
c leukocytes to the endometrium and those that modulate the function o
r replication of leukocytes in this tissue are not well defined. In th
is study, we evaluated the potential for synthesis of monocyte chemota
ctic protein-1 (MCP-1), a polypeptide with monocyte/macrophage chemota
ctic and activating properties, in human endometrium and in separated
endometrial stromal and epithelial cells. MCP-1 mRNA was readily detec
ted by northern analysis of total RNA isolated from human endometrial
tissue (n= 39 tissues from ovulatory women; n = 3 atrophic endometria
from anovulatory women; n = 6 from women ingesting oral contraceptives
or medroxyprogesterone acetate) and decidua parietalis at midtrimeste
r (n = 6 pregnancies) and at term (n = 6 pregnancies). The levels of M
CP-1 mRNA varied considerably among tissues; but in this relatively sm
all number of samples, there was no apparent relationship between day
of cycle, endocrine status, or duration of pregnancy and the level of
MCP-1 mRNA. MCP-1 mRNA was detected in separated endometrial stromal c
ells and epithelial cells in culture. In confluent human endometrial s
tromal cells in the absence or presence of fetal bovine serum (10%, v/
v), MCP-1 mRNA was detected by northern analysis of total RNA. Fetal b
ovine serum effected a concentration-dependent decrease in the levels
of MCP-1 mRNA. The level of MCP-1 mRNA in endometrial stromal cells ma
intained in serum-free medium increased in a time- and concentration-d
ependent manner in response to treatment with interleukin-1 alpha or t
umor necrosis factor-alpha. Platelet-derived growth factor and interfe
ron-alpha also acted, in a concentration-dependent manner, to increase
the level of MCP-1 mRNA.